Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 371087, 14 pages
http://dx.doi.org/10.1155/2014/371087
Clinical Study

Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report

1Department of Bio-Therapy, College of Life Sciences, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China
2Department of Geriatric Hematology, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China
3Department of Immunology, Institute of Basic Medicine, Medical College of PLA, Chinese PLA General Hospital, Beijing 100853, China

Received 26 December 2013; Revised 21 March 2014; Accepted 10 April 2014; Published 21 May 2014

Academic Editor: Shigeo Koido

Copyright © 2014 Hui Fan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hui Fan, Xuechun Lu, Xiaohui Wang, et al., “Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report,” Journal of Immunology Research, vol. 2014, Article ID 371087, 14 pages, 2014. https://doi.org/10.1155/2014/371087.